[
  {
    "ts": null,
    "headline": "Galapagos Plans to Split Into Two Entities, Revise Agreement With Gilead Sciences, Reduce Workforce by 40%",
    "summary": "Galapagos (GLPG) said Wednesday that it plans to split into two entities, with a new company, or Spi",
    "url": "https://finnhub.io/api/news?id=456d2af91e4980863bf502b2f28c9b6223a4bd946a1b77cf8e6739d296e9b4e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736338605,
      "headline": "Galapagos Plans to Split Into Two Entities, Revise Agreement With Gilead Sciences, Reduce Workforce by 40%",
      "id": 132315567,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Galapagos (GLPG) said Wednesday that it plans to split into two entities, with a new company, or Spi",
      "url": "https://finnhub.io/api/news?id=456d2af91e4980863bf502b2f28c9b6223a4bd946a1b77cf8e6739d296e9b4e1"
    }
  },
  {
    "ts": null,
    "headline": "2024 Performance Review And Future Strategy",
    "summary": "My 2024 picks outperformed the S&P 500, mainly due to Tesla, but small biotech firms lagged significantly. Learn more about my 2024 performance here.",
    "url": "https://finnhub.io/api/news?id=3922811a6b45756cc6f38314d6b95f2b71818045c9380e9535a68114ed74797a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736307720,
      "headline": "2024 Performance Review And Future Strategy",
      "id": 132312972,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "My 2024 picks outperformed the S&P 500, mainly due to Tesla, but small biotech firms lagged significantly. Learn more about my 2024 performance here.",
      "url": "https://finnhub.io/api/news?id=3922811a6b45756cc6f38314d6b95f2b71818045c9380e9535a68114ed74797a"
    }
  },
  {
    "ts": null,
    "headline": "Netherland's Galapagos to spin off innovative medicines business",
    "summary": "-Dutch pharmaceutical firm Galapagos said on Wednesday it was planning to split into two listed entities by mid-2025, creating a new company focused on innovative medicines. Galapagos...",
    "url": "https://finnhub.io/api/news?id=89b5f627285cfa7a538a929f672f679bdfcc3baae423ae03f762d4d2e05c5b06",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736306030,
      "headline": "Netherland's Galapagos to spin off innovative medicines business",
      "id": 132312765,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "-Dutch pharmaceutical firm Galapagos said on Wednesday it was planning to split into two listed entities by mid-2025, creating a new company focused on innovative medicines. Galapagos...",
      "url": "https://finnhub.io/api/news?id=89b5f627285cfa7a538a929f672f679bdfcc3baae423ae03f762d4d2e05c5b06"
    }
  }
]